Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$3.91
+0.26%
Mkt Cap $402.14M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+206.9%
Consensus $12.00 vs current $3.91
NASDAQ·Healthcare·Biotechnology
$3.91
+0.26%
Mkt Cap $402.14M
No recent rating data.
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
+206.9%
Consensus $12.00 vs current $3.91